Blocking the effects of IL‐18 reduces the atherosclerotic lesion size and induces a switch to a stable plaque phenotype, whereas both endogenous and exogenous IL‐18 accelerated atherosclerosis development 31, 32, suggesting IL‐37 may play a protective role in atherosclerosis via inhibiting IL‐18. The gene discussed is IL37; the disease is atherosclerosis.